Log in

Start Your Membership Now

November 1, 2010 The report includes a list of medications being developed to treat Alzheimer's disease; it lists each compound name, the developer, the proposed use for the compound, and the development status of medications in the pipeline to be approved by the U.S. Food and Drug Administration. The report was based on industry data and the Adis R&D Insight database. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resources